`
`U.S. Patent No. 9,220,631
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`REGENERON PHARMACEUTICALS,INC.,
`Petitioner
`
`V.
`
`NOVARTIS PHARMAAG,
`NOVARTIS TECHNOLOGY LLC,
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owners
`
`Case IPR2021-00816
`Patent 9,220,631
`
`PATENT OWNER NOVARTIS TECHNOLOGYLLC’S
`UPDATED POWER OF ATTORNEY
`
`
`
`U.S. Patent No. 9,220,631
`
`Pursuant to 37 C.F.R. § 42.10(b), Patent Owner, Novartis Technology
`LLC, hereby appoints Allen & Overy LLP andthe following practitionersas its
`
`attorneys to transact all business in the United States Patent & Trademark Office
`
`associated with the above-captioned interpartes review:
`
`
`
`
`
`4
`
` Lead Counsel:
`First Backup Counsel:
`|
`Nicholas K. Mitrokostas (pro hac vice)
`ALLEN & OVERY LLP
`1 Beacon Street
`Boston, MA 02108
`Phone: (857) 353-4503
`nicholas.mitrokostas@allenovery.com
`
`Elizabeth J. Holland (Reg. No. 47,657)
`ALLEN & OVERY LLP
`221 Avenueof the Americas
`New York, NY 10020
`Phone: (212) 610-6300
`elizabeth.holland@allenovery.com
`
`
`ackup Counsel:
`
`William G. James (Reg. No. 55,931)
`ALLEN & OVERY LLP
`1101 New York Ave, N.W.
`Washington, D.C, 20005
`Phone: (202) 683-3800
`william.james@allenovery.com
`
`
`
`The individuals signing below have the authority to execute this document on
`
`U.S, Patent No. 9,220,631
`
`behalf of Patent Owner Novartis Technology LLC.
`
`
`
`Dated: July|3, 2022 ‘
`
`etha C Has len
`Name:
`
`
`Title:ExeorrhiveDirecturTanste'
`Mean
`
`Name:
`
`Title:
`
`
`
`U.S. Patent No. 9,220,631
`
`CERTIFICATE OF SERVICE
`
`A copy ofthis Patent Owner Novartis Technology LLC’s Updated Power
`
`of Attorney has been servedon Petitioner’s attorneys of record as follows via
`
`electronic mail:
`
`Elizabeth Stotland Weiswasser
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8022
`F; 212-310-8007
`elizabeth.weiswasser(@weil.com
`USPTO Reg.No. 55,721
`
`Anish R. Desat
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`F: 212-310-8007
`anish.desai@weil.com
`USPTO Reg. No. 73,760
`
`Natalie Kennedy
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`F: 212-310-8007
`natalie.kennedy@weil.com
`USPTOReg.No. 68,511
`
`Andrew Gesior
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`
`
`
`U.S. Patent No. 9,220,631
`
`USPTOReg. No. 76,588
`
`Christopher M. Pepe
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`T: 202-682-7000
`F: 202-857-0940
`christopher.pepe@weil.com
`USPTOReg.No. 73,851
`
`Matthew D. Sieger
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`T: 202-682-7000
`F: 202-857-0940
`matthew.sieger@weil.com
`USPTOReg. No. 76,051
`
`Priyata Y. Patel
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`T: 202-682-7000
`F: 202-857-0940
`priyata.patel@weil.com
`USPTO Reg.No. 76,861
`
`Regeneron.IPR.Service@weil.com
`
`Petra Scamborova
`Regeneron Pharmaceuticals, Inc.
`777 Old Saw Mill River Road
`Tarrytown, NY 10591
`T: 914-847-7611
`petra.scamborova@regeneron.com
`Admittedpro hac vice
`
`James T. Evans
`
`
`
`T: 914-847-7000
`
`j runes.evans@regeneron.com
`USPTO Reg. No. 64,377
`
`
`
`U.S. Patent No. 9,220,631
`
`
`
`Attorneys for Regeneron Pharmaceuticals, Inc.
`
`
`
`
`
`Dated: July13, 2022 By: /Elizabeth J. Hollandi
`
`
`Elizabeth J. Holland (Reg. No. 47,657)
`ALLEN & OVERY LLP
`221 A venue of the Americas
`New York, NY 10020
`Tel: (212) 610-6300
`elizabeth.holland@allenovery.com
`
`
`
`
`
`Attorney for Patent Owners
`
`